tiprankstipranks
Genocea Biosciences (GNCAQ)
OTHER OTC:GNCAQ
US Market

Genocea Biosciences (GNCAQ) Financial Statements

Compare
738 Followers

Genocea Biosciences Financial Overview

Genocea Biosciences's market cap is currently $59.00. The company's EPS TTM is $; its P/E ratio is ―; Genocea Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18Dec 17
Income Statement
Total Revenue
Gross Profit$ 1.64M$ 1.36M---
Operating Income$ -52.10M$ -46.99M$ -38.99M$ -39.52M$ -52.64M
EBITDA$ -30.01M$ -40.74M$ -36.91M$ -25.70M$ -53.75M
Net Income$ -33.20M$ -43.71M$ -38.95M$ -27.81M$ -56.71M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 55.97M$ 98.49M$ 52.61M$ 31.11M$ 17.49M
Total Debt$ 8.79M$ 13.86M$ 13.41M$ 14.82M$ 14.31M
Net Debt$ -28.31M$ -65.91M$ -26.72M$ -11.54M$ 2.04M
Total Liabilities$ 28.89M$ 89.51M$ 27.57M$ 23.78M$ 23.54M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -48.61M$ -44.21M$ -38.82M$ -41.37M$ -48.82M
Operating Cash Flow$ -45.40M$ -41.65M$ -37.73M$ -41.23M$ -47.80M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Genocea Biosciences Earnings and Revenue History

Genocea Biosciences Debt to Assets

Genocea Biosciences Cash Flow

Genocea Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis